
Loreal's strategic acquisitions have been a key driver of business growth and innovation. The company has made several significant purchases in the past decade, including its acquisition of The Body Shop in 2006.
This move helped L'Oreal expand its presence in the global beauty market, particularly in the natural and organic segment. The Body Shop's expertise in this area complemented L'Oreal's existing product lines.
L'Oreal's acquisition strategy has also enabled the company to tap into new markets and technologies. Its purchase of Kiehl's in 2000, for example, gave L'Oreal access to the premium skincare market.
This focus on expansion and innovation has contributed to L'Oreal's position as a leader in the beauty industry.
Additional reading: Sally Beauty Holdings
L'Oréal Acquisitions
L'Oréal has been making some big moves in the beauty industry, and their recent acquisitions are a great example of this. L'Oréal is buying Australian brand Aesop in a deal that values it at $2.5 billion, the biggest brand acquisition ever made by the French beauty giant.
The acquisition is expected to close in the third quarter of this year, and it will bring Aesop under the same umbrella as brands such as Garnier and Maybelline. This deal is L'Oréal's largest acquisition of another brand on record, followed by its $1.7 billion purchase of YSL Beauté in 2008.
L'Oréal's CEO, Nicolas Hieronimus, is excited about the potential of Aesop, stating that it "taps into all of today's ascending currents" and has "massive growth potential, notably in China and travel retail." This is a big deal for L'Oréal, and it's likely to have a significant impact on the beauty industry as a whole.
L'Oréal has also acquired a majority stake in Medik8, a British premium skincare brand, as part of its Luxe Division. This acquisition further strengthens L'Oréal's Luxe portfolio, adding a premium science-backed skincare brand with a proven track record of success.
A unique perspective: Nvidia Growth Potential
L'Oréal Business Updates
L'Oréal has signed an agreement to acquire a majority stake in Medik8, a British premium skincare brand.
Medik8 will join L'Oréal's Luxe Division, adding a premium science-backed skincare brand with a proven track record of success.
The Founder, Elliot Isaacs, will continue to serve on the board, and the current management committee will remain in place to ensure continuity.
Medik8 is best known for its iconic Crystal Retinal serum and its trademark CSA Philosophy: Vitamin C and Sunscreen by Day, Vitamin A by night.
The brand offers ingredient-led premium skincare to deliver "results without compromise" and has evolved towards a diversified omni-channel sales mix across prominent online and offline retailers in Europe.
L'Oréal will start consolidating Medik8 sales from the date of the closing of the transaction.
Inflexion, a leading European mid-market private equity firm, will remain a minority shareholder.
Broaden your view: O Que É Mbtc
Frequently Asked Questions
Who owns L'Oréal right now?
L'Oréal's ownership is divided among the Bettencourt family (34.73%), Nestlé (20.13%), and international institutional investors (30.7%), among others. The company's ownership structure is complex, with multiple stakeholders holding significant shares.
Featured Images: pexels.com


